Sales and Marketing

Showing 15 posts of 11527 posts found.

AstraZeneca constipation drug gets EU nod

December 9, 2014 Sales and Marketing AstraZeneca, KODIAC, NKTR-118, PAMORA, moventig, naloxegol

AstraZeneca’s opioid-induced constipation drug Moventig has been approved by the European Commission. The first once-daily PAMORA tablet to be given …

NICE U-turn over Janssen arthritis drug

December 9, 2014 Sales and Marketing Janssen, NHS, NICE, Stelara, arthritis, ustekinumab

NICE has reversed its decision on Janssen’s Stelara and is now recommending the active psoriatic arthritis drug. The pricing watchdog …

Mixed results for new leukaemia drugs

December 9, 2014 Research and Development, Sales and Marketing AML, Bayer, Nexavar, Qinprenzo, Sunesis Pharmaceuticals, sorafenib

Two trials of new drugs for acute myeloid leukaemia (AML) have shown promising results in younger and older groups of …

Novartis biosimilar rivals Amgen offering

December 9, 2014 Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

Ranbaxy and Sun Pharma merger approved

December 9, 2014 Manufacturing and Production, Sales and Marketing FDA, Ranbaxy, Sun Pharma, cci, tamsulosin, tolterodine

The Competition Commission of India (CCI) has approved Sun Pharma’s acquisition of struggling drugmaker Ranbaxy, subject to conditions designed to …

Pfizer buys into gene therapy

December 9, 2014 Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …

Celgene appoints new UK general manager

December 9, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Wim Souverijns

Celgene has appointed Wim Souverijns as its new vice president and general manager for UK and Ireland. Souverijns (pictured) takes …

AZ triumphs in Nexium pay-for-delay trial

December 8, 2014 Sales and Marketing AstraZeneca, Dr Reddy's, Nexium, Ranbaxy, dr reddys, esomeprazole

AstraZeneca and Ranbaxy have avoided what might have been a $10 billion pay out regarding delays to the generic version …

Updated: Merck buys antibiotics specialist Cubist

December 8, 2014 Sales and Marketing Antibiotics, Merck, Novartis, cubicin, cubist, eumer

Merck has purchased US antibiotics maker Cubist in a deal valued at $9.5 billion. The acquisition values Cubist at around …

Blackberry creates cancer diagnostic tool

December 8, 2014 Medical Communications, Sales and Marketing Blackberry, chen, diagnostic, nanthealth, passport, soon-shiong

Canadian smartphone maker Blackberry is entering the healthcare arena with a cancer diagnostic tool aimed at doctors and nurses. Via …

Merck and Galderma breach ABPI code

December 8, 2014 Medical Communications, Sales and Marketing ABPI, Erbitux, Galderma, PMCPA, merch

Merck Serono and Galderma will be named in advertisements as guilty of the most serious breach of the ABPI Code …

Analysis finds no Actos bladder cancer link

December 8, 2014 Sales and Marketing Actos, Cancer, Takeda, bladder, lilly, pioglitazone, type 2

A large-scale analysis of patient data has found that pioglitazone, the diabetes drug that is the subject of ongoing safety …

The valuable world of Real World Evidence

December 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …

ABPI appoints first manufacturing director

December 8, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie

The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …

Bayer files haemophilia drug in EU

December 5, 2014 Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate

Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …
The Gateway to Local Adoption Series

Latest content